Washington State DOH admits Jessica Wilson died “from a blood clot after receiving the J & J vaccine”, Downplays significance, Dr. Noorchashm warned FDA and public of danger of vaccinating naturally infected
“Why are we vaccinating healthy adults when 81 percent of Covid-19 cases are mild and there is a 99 percent survival rate. Why are we testing vaccines on children who are minimally impacted by the disease?”…Citizen Wells
“it is my sincere hope that this public letter might stimulate FDA, Pfizer and Moderna leaders to think critically and quickly about the immunological danger the COVID-19 vaccine might pose to those persons naturally infected by SARS-CoV-2 — most especially to those infected who are recently convalescent, asymptomatic carriers, the elderly and frail or those with significant cardiovascular risk factors.”...Dr. Hooman Noorchashm“
“Jessica felt coerced. She felt robbed of her ability to choose, her ability to say, ‘No,’ to say, ‘No’ to a medical procedure she did not want was taken from her.”…Jessica Wilson’s uncle
“Statement from the Washington State Department of Health
OLYMPIA – The Washington State Department of Health (DOH) is aware of the recent death of a King County woman from a blood clot after receiving the J & J vaccine.
“Sadly, this is the first such death in Washington State. We send our deepest condolences to her family and loved ones. Losing a loved one at any time is a tragic and difficult and pain that’s become all too familiar in the last year and a half of this pandemic.” says Umair A. Shah, MD, MPH, Secretary of Health.
Blood clots are a very rare complication associated with the Johnson & Johnson COVID-19 vaccine, and the Centers for Disease Control and Prevention (CDC) has reported only three other confirmed deaths nationwide, with this being the first in Washington state. Adverse events associated with vaccines are reported through the Vaccine Adverse Event Reporting System (VAERS) here.
DOH will continue working closely with Public Health Seattle-King County and the CDC as more details become available.”
Was Jessica Wilson naturally infected?
Was she asymptomatic?
From Dr. Hooman Noorchashm January 26, 2021.
“A Letter of Warning To FDA And Pfizer: On The Immunological Danger Of COVID-19 Vaccination In The Naturally Infected.
Dear Reader, it is my sincere hope that this public letter might stimulate FDA, Pfizer and Moderna leaders to think critically and quickly about the immunological danger the COVID-19 vaccine might pose to those persons naturally infected by SARS-CoV-2 — most especially to those infected who are recently convalescent, asymptomatic carriers, the elderly and frail or those with significant cardiovascular risk factors.”
“I am writing to warn that it is an almost certain immunological prognotication that if viral antigens are present in the tissues, any tissues, of subjects who undergo vaccination, the antigen specific immune response triggered by the vaccine will target those tissues and cause inflammation and damage beyond the local anatomic site of vaccine placement.
Most pertinently, when viral antigens are present in the vascular endothelium or other layers of the blood vessel, and especially in elderly and frail with cardiovascular disease, the antigen specific immune response incited by the vaccine is almost certain to do damage to the vascular endothelium. Such vaccine directed endothelial damage is certain to cause blood clot formation with the potential for major thromboembolic complications, at least in a subset of such patients. If a majority of younger more robust patients might tolerate such vascular injury from a vaccine immune response, many elderly and frail patients with cardiovascular disease almost certainly will not.
Therefore, it is my respectful request that FDA, in collaboration with Pfizer and Moderna, immediately and at the very minimum, institute clear recommendations to clinicians that they delay or avoid immunization in any recently convalescent patients, as well as, any “known or suspected” symptomatic or asymptomatic carriers — and to actively screen as many patients with high cardiovascular risk as is reasonably possible, in order to detect the recent or current presence of SARS-CoV-2, prior to vaccinating them.”
Why are we not screening people prior to vaccinating and warning of potential dangers of the experimental Covid-19 vaccine?